Torii Pharmaceutical : Positive Top line Results of Phase 3 Clinical Study (Comparative Study) of JTE 061 (tapinarof) Cream, Aryl hydrocarbon Receptor (AhR) agonist, in Pediatric Patients with Atopic Dermatitis in Japan

FOR IMMEDIATE RELEASE


Tokyo, May 31, 2024


Positive Top-line Results of Phase 3 Clinical Study of JTE-061 Cream, Aryl hydrocarbon Receptor ...

Related Keywords

Tokyo ,Japan , ,Japan Tobacco Inc ,Dermavant Sciences Gmbh ,Torii Pharmaceutical Co Ltd ,Top Line Results ,Comparative Study ,Pediatric Patients ,Atopic Dermatitis ,Eczema Area ,Severity Index ,